Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
HRMY earnings call for the period ending March 31, 2024.
Source: fool.com
Harmony Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Harmony Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Harmony Bioscience Today - Breaking & Trending Today
Pitolisant Granted Orphan Drug Status in Prader-Willi Syndrome
The FDA has granted Orphan Drug designation to Harmony Bioscience’s pitolisant for the treatment of Prader-Willi syndrome.
Source: sleepreviewmag.com
Pitolisant May Improve Sleepiness in Myotonic Dystrophy Patients
Phase 2 study results reveal pitolisant significantly improved daytime sleepiness and fatigue in myotonic dystrophy type 1 patients.
Source: sleepreviewmag.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Forecasted to Post FY2024 Earnings of $2.90 Per Share
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) – Equities research analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a research report issued to clients and investors on Wednesday, November 1st. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings per share of […]
Source: dailypolitical.com